Gloria Huerta-Ángeles

Dr. Gloria Huerta-Ángeles

Czech Academy of Sciences, Institute of Macromolecular Chemistry, Prague, Praha, Hlavní Město, Czech Republic
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
DŠDaniela Šmejkalová
Daniela Šmejkalová
TMTomáš Muthný
Tomáš Muthný
KNKristina Nešporová
Kristina Nešporová
MHMartina Hermannová
Martina Hermannová
EAEva Achbergerová
Eva Achbergerová
VVVladimír Velebný
Vladimír Velebný

28 December 2009 in The Journal of Physical Chemistry C
Verified
Journal Article
Closed access
PRPhilipp Rahe
Philipp Rahe
MNMarkus Nimmrich
Markus Nimmrich
AGAndreas Greuling
Andreas Greuling
JSJens Schütte
Jens Schütte
ISIrena G. Stará
Irena G. Stará
AKAngelika Kühnle
Angelika Kühnle

17 May 2018 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
Gloria Huerta-ÁngelesGloria Huerta-Ángeles
Gloria Huerta-Ángeles
KNKristina Nešporová
Kristina Nešporová
GAGabriela Ambrožová
Gabriela Ambrožová
Lukas KubalaLukas Kubala
Lukas Kubala
VVVladimir Velebný
Vladimir Velebný
This review shows the steps toward material selection focalized on the design and development of medical devices based on hyaluronan (HA). The selection is based on chemical and mechanical properties, biocompatibility, sterilization, safety, and scale-up costs. These facts play a vital role in the industrialization process. Approved medical devices containing-HA are illustrated to identify key parameters. The first part of this work involves the steps toward a complete characterization of chemical and mechanical aspects, reproducibility of the processes and scale up. In a second stage, we aimed to describe the preclinical in vitro and in vivo assays and selected examples of clinical trials. Furthermore, it is important to keep in mind the regulatory affairs during the research and development (R&D) using standardization (ISO standards) to achieve the main goal, which is the functionality and safety of the final device. To keep reproducible experimental data to prepare an efficient master file for the device, based on quality and recorded manufacturing data, and a rigorous R&D process may help toward clinical translation. A strong debate is still going on because the denominated basic research in HA field does not pay attention to the purity and quality of the raw materials used during the development. So that, to achieve the next generation of devices is needed to overcome the limitations of state of art in terms of efficacy, biodegradability, and non-toxicity.

13 October 2014 in Biomacromolecules
Verified
Journal Article
Closed access
DŠDaniela Šmejkalová
Daniela Šmejkalová
KNKristina Nešporová
Kristina Nešporová
Gloria Huerta-ÁngelesGloria Huerta-Ángeles
Gloria Huerta-Ángeles
JSJakub Syrovátka
Jakub Syrovátka
DJDaniel Jirák
Daniel Jirák
VVVladimír Velebný
Vladimír Velebný

10 November 2022 in Polymers
Verified
Journal Article
Open access
PDF file
MJMartin Juhaščik
Martin Juhaščik
AKAndrej Kováčik
Andrej Kováčik
Gloria Huerta-ÁngelesGloria Huerta-Ángeles
Gloria Huerta-Ángeles
Hyaluronan (HA) plays a fundamental role in maintaining the homeostasis on skin health. Furthermore, the effect of HA in skin inflammatory diseases is worth studying in the next future. HA and its conjugates change the solubility of active pharmaceutical ingredients, improve emulsion properties, prolong stability, reduce immunogenicity, and provide targeting. HA penetrates to deeper layers of the skin via several mechanisms, which depend on the macromolecular structure and composition of the formulation. The cellular and molecular mechanisms involved in epidermal dysfunction and skin aging are not well understood. Nevertheless, HA is known to selectively activate CD44-mediated keratinocyte signaling that regulates its proliferation, migration, and differentiation. The molecular size of HA is critical for molecular mechanisms and interactions with receptors. High molecular weight HA is used in emulsions and low molecular weight is used to form nanostructured lipid carriers, polymeric micelles, bioconjugates, and nanoparticles. In the fabrication of microneedles, HA is combined with other polymers to enhance mechanical properties for piercing the skin. Hence, this review aims to provide an overview of the current state of the art and last reported ways of processing, and applications in skin drug delivery, which will advocate for their broadened use in the future.

1 April 2013 in Carbohydrate Research
Verified
Journal Article
Closed access
PŠPetra Šedová
Petra Šedová
RBRadovan Buffa
Radovan Buffa
SKSofiane Kettou
Sofiane Kettou
Gloria Huerta-ÁngelesGloria Huerta-Ángeles
Gloria Huerta-Ángeles
MHMartina Hermannová
Martina Hermannová
VVVladimír Velebný
Vladimír Velebný